Literature DB >> 18482194

Flow cytometric measurement of CD62P (P-selectin) expression on platelets: a multicenter optimization and standardization effort.

Joyce Curvers1, Janny de Wildt-Eggen, Judith Heeremans, John Scharenberg, Dirk de Korte, Pieter F van der Meer.   

Abstract

BACKGROUND: One of the variables to determine the quality of platelets (PLTs) in vitro is measurement of CD62P expression. Different protocols are in use, however, making comparison of results virtually impossible. It was our aim to develop a uniform CD62P protocol that would yield comparable results in various laboratories. STUDY DESIGN AND METHODS: The effects of fixation, source and dilution of CD62P antibody, source of immunoglobulin G (IgG) isotypic antibody, and analysis of results were investigated. Once the optimal variables were defined, comparative studies were performed at five participating centers. In the final comparative study, eight split PLT concentrates were shipped to the centers, where samples were stained and fixed according to the uniform protocol. Analyses were performed using commercially available flow cytometers (BD Biosciences and Beckman Coulter).
RESULTS: Uniformity between centers could be achieved by using a single clone for CD62P and IgG monoclonal antibody. A protocol was selected using fixation with 0.5 percent methanol-free formaldehyde. To increase conformity between flow cytometers, in the analysis of electronic data the thresholds of the isotypic control were set at 0.5 percent for the BD Biosciences and 2 percent for the Beckman Coulter flow cytometers. In the final comparative study, the 95 percent confidence intervals (CIs) for CD62P ranged between 8 and 21 percent in fresh and 20 to 40 percent in 8-day-old PLT concentrates.
CONCLUSION: A uniform CD62P staining protocol and subsequent analysis can be used at multiple centers using different flow cytometers, yielding comparable results with acceptable 95 percent CIs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18482194     DOI: 10.1111/j.1537-2995.2008.01738.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  9 in total

1.  Assessment of Time-Dependent Platelet Activation Using Extracellular Vesicles, CD62P Exposure, and Soluble Glycoprotein V Content of Platelet Concentrates with Two Different Platelet Additive Solutions.

Authors:  Sami Valkonen; Birte Mallas; Ulla Impola; Anne Valkeajärvi; Juha Eronen; Kaija Javela; Pia R-M Siljander; Saara Laitinen
Journal:  Transfus Med Hemother       Date:  2019-05-07       Impact factor: 3.747

Review 2.  Myelodysplastic Syndromes: Laboratory Workup in the Context of New Concepts and Classification Criteria.

Authors:  Maria Sanz-De Pedro; Wei Wang; Rashmi Kanagal-Shamanna; Joseph D Khoury
Journal:  Curr Hematol Malig Rep       Date:  2018-12       Impact factor: 3.952

3.  Laropiprant attenuates EP3 and TP prostanoid receptor-mediated thrombus formation.

Authors:  Sonia Philipose; Viktoria Konya; Mirjana Lazarevic; Lisa M Pasterk; Gunther Marsche; Sasa Frank; Bernhard A Peskar; Akos Heinemann; Rufina Schuligoi
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

4.  Space and Time Resolved Detection of Platelet Activation and von Willebrand Factor Conformational Changes in Deep Suspensions.

Authors:  Jacopo Biasetti; Kaushik Sampath; Angel Cortez; Alaleh Azhir; Assaf A Gilad; Thomas S Kickler; Tobias Obser; Zaverio M Ruggeri; Joseph Katz
Journal:  Int J Biomed Imaging       Date:  2017-11-06

5.  Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients.

Authors:  Agnieszka Morel; Joanna Rywaniak; Michał Bijak; Elżbieta Miller; Marta Niwald; Joanna Saluk
Journal:  Mol Cell Biochem       Date:  2017-02-16       Impact factor: 3.396

Review 6.  Platelets as a Gauge of Liver Disease Kinetics?

Authors:  Sheng-Hung Chen; Shih-Chang Tsai; Hsiu-Chen Lu
Journal:  Int J Mol Sci       Date:  2022-09-28       Impact factor: 6.208

7.  Proteomic and phospho-proteomic profile of human platelets in basal, resting state: insights into integrin signaling.

Authors:  Amir H Qureshi; Vineet Chaoji; Dony Maiguel; Mohd Hafeez Faridi; Constantinos J Barth; Saeed M Salem; Mudita Singhal; Darren Stoub; Bryan Krastins; Mitsunori Ogihara; Mohammed J Zaki; Vineet Gupta
Journal:  PLoS One       Date:  2009-10-27       Impact factor: 3.240

8.  Analysis of platelet-activating factors in severe sepsis by flow cytometry and its correlation with clinical sepsis scoring system: A pilot study.

Authors:  V Manu; Barun K Chakrabarty; Shivinder Singh
Journal:  Med J Armed Forces India       Date:  2018-10-10

9.  The Molecular Aspects of Disturbed Platelet Activation through ADP/P2Y12 Pathway in Multiple Sclerosis.

Authors:  Angela Dziedzic; Elzbieta Miller; Joanna Saluk-Bijak; Marta Niwald; Michal Bijak
Journal:  Int J Mol Sci       Date:  2021-06-18       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.